drugset / Trial / NCT02998840

A Prospective Study of B244 Delivered as a Topical Spray to Determine Safety and Efficacy in Subjects With Elevated Blood Pressure

NCT02998840 ↗

Phase 2 Completed 132 enrolled AOBiome LLC Veristat, Inc. · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate and compare the efficacy of B244 in treating patients with hypertension.

Timeline

Start
2016-11
Primary completion
2017-04-25
Completion
2017-06-26

Drugs

EvaluationDrugModalityDoseRoute
Comparator B244 Other / unclassified — Topical

Indications